Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Retained Earnings (2020 - 2025)

GeneDx Holdings has reported Retained Earnings over the past 6 years, most recently at $936000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $936000.0 for Q4 2025, up 100.07% from a year ago — trailing twelve months through Dec 2025 was $936000.0 (up 100.07% YoY), and the annual figure for FY2025 was $936000.0, up 100.07%.
  • Retained Earnings for Q4 2025 was $936000.0 at GeneDx Holdings, down from $1.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for WGSWW hit a ceiling of $1.0 million in Q3 2025 and a floor of -$1.4 billion in Q1 2025.
  • Median Retained Earnings over the past 5 years was -$613.9 million (2021), compared with a mean of -$662.5 million.
  • Biggest five-year swings in Retained Earnings: plummeted 940215.87% in 2021 and later soared 100.07% in 2024.
  • GeneDx Holdings' Retained Earnings stood at -$575.4 million in 2021, then plummeted by 95.4% to -$1.1 billion in 2022, then soared by 100.04% to $425000.0 in 2023, then crashed by 318329.18% to -$1.4 billion in 2024, then skyrocketed by 100.07% to $936000.0 in 2025.
  • The last three reported values for Retained Earnings were $936000.0 (Q4 2025), $1.0 million (Q3 2025), and $812000.0 (Q2 2025) per Business Quant data.